Share Twitter LinkedIn Facebook Email David R. Gandara, MD, explains what will change about patient selection as a result of Keynote 42 at Annual Meeting 2018. Advertisement
ASCO 2025: Lung Cancer Immunotherapy Breakthroughs from the Immuno-Oncology Symposium Lung Cancer Treatment 4 Mins Read
